Stereotaxis (STXS) Reports Q4 Loss Per Share of $0.10
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/25/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- Lula, Brazil's iconic working class president, wins historic fourth term in dramatic comeback
- LKQ posts Q3 loss, replaces CEO amid Europe struggles
- Accenture shares fall on insider sales and analyst downgrade
- Wall Street closes lower to end rocky week
- Credo Technology shares fall on competition concerns
Stereotaxis Reports 2015 Fourth Quarter and Full Year Financial Results
February 22, 2016 4:05 PM ESTNew capital orders of $5.1 million in the fourth quarter, including two Niobe® ES system orders in JapanFourth quarter free cash flow of $1.6 million, driving a 71% reduction in full year cash burn compared to 2014Ventricular Tachycardia procedures in the fourth quarter grew 28% year over year, with increased clinical evidence supporting Stereotaxis technology as the standard of careTotal revenue for 2015 increased 8% year over year to $37.7 millionFull year systems revenue increased 36% year over year on seven Niobe® ES system sales, up from three in 2014Conference call today at 4:30 p.m. Eastern Time
ST. LOUIS, Feb.... More



